Literature DB >> 26508031

Esculetin, a natural coumarin compound, evokes Ca(2+) movement and activation of Ca(2+)-associated mitochondrial apoptotic pathways that involved cell cycle arrest in ZR-75-1 human breast cancer cells.

Hong-Tai Chang1, Chiang-Ting Chou2,3, You-Sheng Lin4, Pochuen Shieh5, Daih-Huang Kuo5, Chung-Ren Jan4, Wei-Zhe Liang6.   

Abstract

Esculetin (6,7-dihydroxycoumarin), a derivative of coumarin compound, is found in traditional medicinal herbs. It has been shown that esculetin triggers diverse cellular signal transduction pathways leading to regulation of physiology in different models. However, whether esculetin affects Ca(2+) homeostasis in breast cancer cells has not been explored. This study examined the underlying mechanism of cytotoxicity induced by esculetin and established the relationship between Ca(2+) signaling and cytotoxicity in human breast cancer cells. The results showed that esculetin induced concentration-dependent rises in the intracellular Ca(2+) concentration ([Ca(2+)]i) in ZR-75-1 (but not in MCF-7 and MDA-MB-231) human breast cancer cells. In ZR-75-1 cells, this Ca(2+) signal response was reduced by removing extracellular Ca(2+) and was inhibited by the store-operated Ca(2+) channel blocker 2-aminoethoxydiphenyl borate (2-APB). In Ca(2+)-free medium, pre-treatment with the endoplasmic reticulum Ca(2+) pump inhibitor thapsigargin (TG) abolished esculetin-induced [Ca(2+)]i rises. Conversely, incubation with esculetin abolished TG-induced [Ca(2+)]i rises. Esculetin induced cytotoxicity that involved apoptosis, as supported by the reduction of mitochondrial membrane potential and the release of cytochrome c and the proteolytic activation of caspase-9/caspase-3, which were partially reversed by pre-chelating cytosolic Ca(2+) with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-acetoxymethyl ester (BAPTA-AM). Moreover, esculetin increased the percentage of cells in G2/M phase and regulated the expressions of p53, p21, CDK1, and cyclin B1. Together, in ZR-75-1 cells, esculetin induced [Ca(2+)]i rises by releasing Ca(2+) from the ER and causing Ca(2+) influx through 2-APB-sensitive store-operated Ca(2+) entry. Furthermore, esculetin activated Ca(2+)-associated mitochondrial apoptotic pathways that involved G2/M cell cycle arrest. Graphical abstract The summary of esculetin-evoked [Ca(2+)]i rises and -activated Ca(2+)-associated mitochondrial apoptotic pathways that involved cell cycle arrest. The natural coumarin derivative esculetin caused Ca(2+) influx via 2-APB-sensitive store-operated Ca(2+) entry and induced Ca(2+) release from the endoplasmic reticulum. Moreover, esculetin activated the mitochondrial pathway of apoptosis in a Ca(2+)-associated manner that involved G2/M arrest.

Entities:  

Keywords:  Ca2+; Cell cycle; Esculetin; Human breast cancer cells; Mitochondrial apoptotic pathway

Mesh:

Substances:

Year:  2015        PMID: 26508031     DOI: 10.1007/s13277-015-4286-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  60 in total

Review 1.  The G2-phase DNA-damage checkpoint.

Authors:  M J O'Connell; N C Walworth; A M Carr
Journal:  Trends Cell Biol       Date:  2000-07       Impact factor: 20.808

Review 2.  Mitochondria as the central control point of apoptosis.

Authors:  S Desagher; J C Martinou
Journal:  Trends Cell Biol       Date:  2000-09       Impact factor: 20.808

Review 3.  The versatility of mitochondrial calcium signals: from stimulation of cell metabolism to induction of cell death.

Authors:  Alessandro Rimessi; Carlotta Giorgi; Paolo Pinton; Rosario Rizzuto
Journal:  Biochim Biophys Acta       Date:  2008 Jul-Aug

4.  Tamoxifen-induced increases in cytoplasmic free Ca2+ levels in human breast cancer cells.

Authors:  Hong-Tai Chang; Jong-Khing Huang; Jue-Long Wang; Jin-Shiung Cheng; Kam-Chung Lee; Yuk-Keung Lo; Chun-Pin Liu; Kang-Ju Chou; Wei-Chung Chen; Warren Su; Yee-Ping Law; Chung-Ren Jan
Journal:  Breast Cancer Res Treat       Date:  2002-01       Impact factor: 4.872

5.  Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.

Authors:  H Yamada; K Watanabe; T Saito; H Hayashi; Y Niitani; T Kikuchi; A Ito; K Fujikawa; L S Lohmander
Journal:  J Rheumatol       Date:  1999-03       Impact factor: 4.666

Review 6.  Overview of resistance to systemic therapy in patients with breast cancer.

Authors:  Ana Maria Gonzalez-Angulo; Flavia Morales-Vasquez; Gabriel N Hortobagyi
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

7.  Human acute promyelocytic leukemia NB4 cells are sensitive to esculetin through induction of an apoptotic mechanism.

Authors:  Virginia Rubio; Eva Calviño; Ana García-Pérez; Angel Herráez; José C Diez
Journal:  Chem Biol Interact       Date:  2014-07-01       Impact factor: 5.192

8.  Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.

Authors:  S Le Bihan; V Marsaud; C Mercier-Bodard; E E Baulieu; S Mader; J H White; J M Renoir
Journal:  Mol Endocrinol       Date:  1998-07

9.  Analysis and distribution of esculetin in plasma and tissues of rats after oral administration.

Authors:  Ji-Sun Kim; Tae-Youl Ha; Jiyun Ahn; Suna Kim
Journal:  Prev Nutr Food Sci       Date:  2014-12-31

10.  Inhibitory effects of nabumetone, a cyclooxygenase-2 inhibitor, and esculetin, a lipoxygenase inhibitor, on N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats.

Authors:  K Matsunaga; N Yoshimi; Y Yamada; M Shimizu; K Kawabata; Y Ozawa; A Hara; H Mori
Journal:  Jpn J Cancer Res       Date:  1998-05
View more
  8 in total

1.  Esculetin has therapeutic potential via the proapoptotic signaling pathway in A253 human submandibular salivary gland tumor cells.

Authors:  Su-Bin Park; Woo Kwon Jung; Hyung Rae Kim; Hwa-Young Yu; Yong Hwan Kim; Junghyun Kim
Journal:  Exp Ther Med       Date:  2022-06-22       Impact factor: 2.751

2.  Chemopreventive Activity of MGN-3/Biobran Against Chemical Induction of Glandular Stomach Carcinogenesis in Rats and Its Apoptotic Effect in Gastric Cancer Cells.

Authors:  Nariman K Badr El-Din; Salma M Abdel Fattah; Deyu Pan; Lucilene Tolentino; Mamdooh Ghoneum
Journal:  Integr Cancer Ther       Date:  2016-05-04       Impact factor: 3.279

3.  Esculetin Inhibits the Survival of Human Prostate Cancer Cells by Inducing Apoptosis and Arresting the Cell Cycle.

Authors:  Kader Turkekul; R Dilsu Colpan; Talha Baykul; Mehmet D Ozdemir; Suat Erdogan
Journal:  J Cancer Prev       Date:  2018-03-30

4.  Esculetin Inhibits Proliferation, Invasion, and Migration of Laryngeal Cancer In Vitro and In Vivo by Inhibiting Janus Kinas (JAK)-Signal Transducer and Activator of Transcription-3 (STAT3) Activation.

Authors:  Geng Zhang; Yi Xu; Hui-Fang Zhou
Journal:  Med Sci Monit       Date:  2019-10-20

5.  Antitumor Effect of the Ethanolic Extract from Seeds of Euphorbia lathyris in Colorectal Cancer.

Authors:  Cristina Mesas; Rosario Martínez; Raúl Ortíz; Milagros Galisteo; María López-Jurado; Laura Cabeza; Gloria Perazzoli; Consolación Melguizo; Jesús M Porres; Jose Prados
Journal:  Nutrients       Date:  2021-02-09       Impact factor: 5.717

Review 6.  Artemisia scoparia and Metabolic Health: Untapped Potential of an Ancient Remedy for Modern Use.

Authors:  Anik Boudreau; Allison J Richard; Innocence Harvey; Jacqueline M Stephens
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-08       Impact factor: 5.555

7.  Bioinformatics analysis of RNA sequencing data reveals multiple key genes in uterine corpus endometrial carcinoma.

Authors:  Liang Shen; Ming Liu; Wei Liu; Jing Cui; Changzhong Li
Journal:  Oncol Lett       Date:  2017-11-03       Impact factor: 2.967

8.  ZR-75-1 breast cancer models to study the utility of 18F-FES by PET imaging.

Authors:  Ziteng Ding; Xudang Xu; Tiannv Li; Jia Wang; Jin Sun; Lijun Tang
Journal:  Transl Cancer Res       Date:  2021-03       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.